- Will include the most contemporary investigational approach to detect asymptomatic fatty liver and its treatment
Kolkata, August, 2022: Liver cirrhosis became the buzzword for every Indian when the great actor Amitabh Bachchan was diagnosed with the condition. But liver cirrhosis is the final stage of what begins in a majority of people condition known as fatty liver. And contrary to popular perception, non-alcoholics are also prone to getting a fatty liver especially if there are issues like diabetes, obesity and abnormal blood cholesterol levels.
Non-alcoholic Fatty liver is one of the most common disease in the world currently affecting about 30% of the global population. According to National Health Portal India, Non Alcoholic Fatty Liver Disease (NAFLD) is a leading cause of chronic liver diseases worldwide. NAFLD affects about 25% of the global population ranging from 13.5% in Africa to 31.8% in the Middle East. The overall prevalence of NAFLD in India has been reported to be close to 30% of the entire population and reaching more than 50 % in those with risk factors like obesity and diabetes.
Fatty liver goes unnoticed most of the time as the disease doesn’t involve any pain or discomfort in the early stages. In an effort to raise awareness about this disease and to provide a holistic treatment for it, Apollo Multispeciality Hospitals today announced the launch of the first ‘Comprehensive Fatty Liver Clinic’ in Eastern India. This clinic will adopt the most contemporary investigational approach to detect asymptomatic fatty liver and its treatment.
As the disease has a silent presentation without any major warning symptoms it becomes important to have appropriate investigations. Hence is the importance of proactive testing like Liver Function Test (LFT) and Ultra Sound (USG). Apollo being the pioneer in healthcare brings the most advanced method of fatty liver test including Fibro Scan and MRI based tests like MRI-PDFF and MR Elastography for the first time in Eastern India. These tests can diagnose the disease at a very early stage, which in turn would help the patients recover faster and not land up at a very critical stage.
Liver is considered fatty when the fat percentage in the organ becomes higher than 5%. People with diabetes, cholesterol, high blood pressure and obesity have about 50-60% chances of having fatty liver disease. Broadly there are 3 stages of fatty liver – Fatty Liver – Steatosis (NAFL), Liver Steatohepatitis (NASH) and Liver Cirrhosis. Among patients with NAFL, 20-25% go on to develop NASH and 10-15% land up having cirrhosis of liver, which is becoming the commonest cause for liver transplantation globally.
With expected 55% increase of adults with Diabetes and +33% increase of adults with Obesity worldwide by 2035 (source: Bril F et al. Diabetes Care 2017, Finkelstein AJPM 2017) cases of liver diseases would also upsurge and the expected increase is by 63% between 2015 and 2030 (source: Younossi et al.J Hep 2018, Estes et al. Hepatol 2019)
Present at the occasion, Dr Mahesh K Goenka – DME & Director & Head Institute of Gastrosciences & Liver Transplant Apollo Multispeciality Hospitals said, “Recent studies and findings have shown that about 35% patients with fatty liver are non-alcoholic and in such patients it’s difficult to reverse the damage because out of sheer unawareness the detection happens much later. Another common trend found in India in last couple of decades is the lean fatty liver, which is seen in people with no sign of obesity. These patients also go unnoticed in the earlier stage of the disease if proactive testing is not followed. With early detection and lifestyle modification fatty liver is curable while it’s difficult to arrest the progression of the disease to cirrhosis if detected late.”
Also presentat the occasion, Dr Surinder Singh Bhatia – DMS (Director Medical Services) mentioned, “Fatty liver even though is more common in young people but it is also found in children with diabetes and/or obesity. Our Comprehensive Fatty Liver Clinic is equipped with all modern investigation methods for diagnosis of asymptomatic fatty liver so that the disease can be arrested at the beginning. In most cases medicine is not the only cure, regular tests and progressions need to be evaluated. The wide approach of treatment to address the disease comprises of doctors’ consultation and lifestyle modification counselling and involvement of various stratas of medical care including primary care, internist, nutritionist, exercise counsellors, endocrinologists, cardiologists, bariatric surgeons.”
About Apollo Hospitals Enterprise Ltd. (AHEL)
It was in 1983, that Dr. Prathap C. Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 71 Hospitals, 3,300 Pharmacies, over 90 Primary Care Clinics and 150 diagnostic centers, 110 plus Telemedicine Centres, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research, Apollo Hospitals has been at the forefront of new medical advancements with the most recent investment being the commissioning of South East Asia’s very first Proton Therapy Centre in Chennai.
Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of international standards within the reach of every individual. In a rare honour, the Government of India had issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C. Reddy, was conferred with the prestigious Padma Vibhushan in 2010.
For 35 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst the best hospitals in the country for advanced medical services.